H

03378

Hanx Biopharmaceuticals (Wuhan)

28.520

+0.040+0.14%
Closed16:08 05/22 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE28.500/28.520
TODAY RANGE27.980-30.000
VOL43.50K
MARKET CAP3.88B
52 WEEK RANGE13.480-32.940
AVG VOL (3M)131.87K
% TURNOVER0.03%
TURNOVER1.25M
P/E (TTM)-26.613
% RANGE7.08%
EPS(TTM)-1.071
P/E(FORWARD)--
P/B4.997
BVPS5.704
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.78B
SHARES OUTSTANDING136.22M
NEXT EARNINGS--
FREE FLOAT132.52M
LOT SIZE100
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

昊海生物科技

06826

-1.38%
20.080

藥明康德

02359

-0.76%
130.000

H

Hangzhou Tigermed Consulting

03347

-1.11%
32.040

昭衍新藥

06127

-3.97%
19.860

康龍化成

03759

-1.29%
18.410

方達控股

01521

+1.11%
0.910

01035

--

中國醫療集團

08225

0.00%
0.125

00233

--

08572

--

邁博藥業-B

02181

0.00%
0.440

維亞生物

01873

0.00%
1.390

中國再生醫學

08158

-6.41%
0.365

東曜藥業-B

01875

+0.68%
4.460

華領醫藥-B

02552

-0.61%
3.260

微創腦科學

02172

+2.14%
9.060

康寧傑瑞製藥-B

09966

+6.25%
9.350

中國抗體-B

03681

+3.85%
1.350

樂普生物

02157

+2.23%
4.580

加科思-B

01167

+0.38%
5.320

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.